Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Public Health topic

No spam. Unsubscribe anytime.

Committee adopts expanded product-registry rules for non-nicotine vapes, including cannabinoid cartridges

Utah House Committee (floor committee)
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Lawmakers approved a substitute and technical amendment to HB 265 to expand Utah’s product registry and enforcement to non-nicotine inhalation products, tighten penalties for unregistered sellers and bar cannabinoid vapes outside the medical cannabis framework.

The committee on Feb. 3 adopted substitute language and a technical amendment to HB 265 and then favorably recommended the first substitute to the House floor. Testimony framed the bill as a response to rapidly evolving vape products marketed as "wellness" items and an attempt to close a regulatory loophole that allows non-nicotine products to evade in-person sale and flavor restrictions.

The sponsor described prior legislative work to regulate flavored nicotine vapes and said regulators have seen the market shift toward products marketed as nicotine-free or as wellness items, including CBD and vitamin vapes. The substitute extends Utah’s electronic product registry and enforcement to cover these non-nicotine inhalation products, escalates civil penalties for sellers who retail unregistered products, and includes guardrails to prevent serial violators from simply reopening under a new name.

Public commenters included Drug Safe Utah and a student witness who urged lawmakers to close the labeling and sales loopholes. Walter Plumb (Drug Safe Utah) said the substitute addresses both so-called wellness products and CBD vaping. Mercedes Branson, a high-school student, told the committee that sellers use the "nicotine-free" label to bypass age-verification and flavor restrictions and urged regulators to treat inhaled cannabinoid products similarly to nicotine vaping products for enforcement purposes.

Committee members adopted the first substitute and amendment, then favorably recommended the amended bill to the House floor.

What comes next: The bill proceeds to the full House; sponsors said regulators will continue technical cleanup as the industry adapts.

Sources: Sponsor presentation, HHS staff, and public comment recorded in committee transcript.